The growth of Viagra and its influence on the drug landscape presents a intricate question for investors. While the early sales figures were impressive, the exclusivity has expired, leading to a flood of off-brand https://zoepkzd863165.blogacep.com/47016500/the-blue-pill-and-big-pharma-a-dangerous-opportunity